Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-16

Clinical Trial Update: Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea [Phase 2]

View source ↗

Summary

Phase 2 trial update for fentanyl buccal tablets evaluating exercise-induced breakthrough dyspnea in patients with advanced cancers; study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fentanyl Buccal Tablets (fentanyl buccal tablet)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers | Phase 2 | Status: COMPLETED | Results posted: 2020-09-16